Home›Research›Compare›MOTS-c vs NAD+
Peptide ComparisonMOTS-c vs NAD+
Both are Longevity & Cellular peptides.
MOTS-c
Mitochondrial ORF of the 12S rRNA type-c
Half-life: Unknown (rapidly cleared from plasma)
185 providers listed
NAD+
NAD
Half-life: ~1–2 hours (IV); variable (oral)
451 providers listed
NAD+ carries stronger published evidence (RCT, 4 key studies) than MOTS-c (Cohort study, 8); both are research compounds.
MOTS-c
Half-life
Unknown (rapidly cleared from plasma)
NAD+
Half-life
~1–2 hours (IV); variable (oral)
| Your goal | Better option |
|---|---|
| Stronger clinical evidence | NAD+ |
| Oral administration option | NAD+ |
| Lower typical price per mg | NAD+ |
| More provider options (185 vs 451) | NAD+ |
Research summary only — not medical advice. Consult a qualified provider before making any decisions.
MOTS-c
NAD+
MOTS-c
Reduced Circulating MOTS-c Levels in Hashimoto's Thyroiditis Reflect Integrated Autoimmune and Metabolic Dysr…
Humanin and MOTS-c Attenuate Atrial Fibrillation by Suppressing Fibrosis and Mitochondrial Dysfunction.
LAT1-mediated delivery of engineered R13A-MOTS-c attenuates radiation-induced lung injury via Nrf2 activation…
MOTS-c attenuates hyperoxia-induced neonatal cardiac injury by inhibiting oxeiptosis via maintaining the KEAP…
+4 more
NAD+
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and…
Mitochondrial quality control in human ageing and longevity.
Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence
About MOTS-c
Mitochondria-derived peptide that translocates to nucleus under stress; activates AMPK pathway, regulates AICAR and folate-methionine cycle
About NAD+
NAD+ is a coenzyme central to cellular energy metabolism, serving as an electron carrier in glycolysis, the citric acid cycle, and oxidative phosphorylation. It is also a required substrate for sirtuins (SIRT1–7) and PARP enzymes, which regulate DNA repair, gene expression, and mitochondrial biogenesis. NAD+ levels decline measurably with age; IV or subcutaneous delivery aims to restore intracellular pools more directly than oral precursors such as NMN or NR.
Information below reflects published research data only — not medical advice. Consult a qualified provider before use.
MOTS-c
No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.
NAD+
No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.
MOTS-c
NAD+
Where to source these peptides
MOTS-c
185 listed
Browse directory →
Providers offeringNAD+
451 listed
Browse directory →
PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.
More Longevity & Cellular Comparisons
Browse all peptides →Educational research tools — not medical advice.
Cite this page
Data last updated August 26, 2026
Free to reference and republish with attribution to PeptideBase. Choose a format:
PeptideBase. (2026). MOTS-c vs NAD+ — Per-mg Price Comparison. Retrieved September 11, 2026, from https://peptidebase.io/peptides/compare/mots-c/nad-plus